STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
- Preleukemia
- +2 more
- Copenhagen, Copenhagen N, DenmarkRigshospitalet
2022-01-20
Jan 20, 2022N
Not yet recruiting
- Myelodysplastic Syndromes
- decitabine and cedazuridine
- BMS-986253
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022A
Completed
- Myelodysplastic Syndromes
- (no location specified)
2022-01-21
Jan 21, 2022T
No longer available
- Myelodysplastic Syndromes
- (no location specified)
2021-09-08
Sep 8, 2021F
Withdrawn
- Myelodysplastic Syndrome (MDS)
- (no location specified)
2021-07-20
Jul 20, 2021C
Active, not recruiting
- Myelodysplastic Syndrome
- Revlimid (Lenalidomide)
- New York, New YorkColumbia University Medical Center
2022-01-12
Jan 12, 2022R
Not yet recruiting
- Low Risk Myelodysplastic Syndromes
- R906289 Monosodium (R289 Na)
- (no location specified)
2022-03-25
Mar 25, 2022D
Completed
- Myelodysplastic Syndromes (MDS)
- Boston, Massachusetts
- +2 more
2022-02-28
Feb 28, 2022N
Recruiting
- Myelodysplasia
- Hematologic Malignancy
- CliniMACS® TCRαβ/CD19 Combined Depletion System
- Columbus, OhioNationwide Children's Hospital
2022-01-11
Jan 11, 2022W
Active, not recruiting
- Myelodysplastic Syndromes
- Saint Louis, MissouriWashington University School of Medicine
2022-03-23
Mar 23, 2022M
Active, not recruiting
- High Risk Myelodysplastic Syndrome
- Houston, TexasM D Anderson Cancer Center
2022-02-02
Feb 2, 2022O
Active, not recruiting
- Lower-risk Myelodysplastic
- Tokyo, JapanNTT Medical Center Tokyo
2022-01-14
Jan 14, 2022U
Recruiting
- High Grade Myelodysplastic Syndromes
- Aurora, ColoradoUniverstiy of Colorado Denver
2021-10-19
Oct 19, 2021T
Recruiting
- Myelodysplastic Syndromes
- Observational
- Dresden, Germany
- +1 more
2021-08-10
Aug 10, 2021T
Withdrawn
- Myelodysplastic Syndromes (MDS)
- Pevonedistat
- +2 more
- (no location specified)
2021-09-23
Sep 23, 2021D
Completed
- Myelodysplastic Syndromes
- Peri-Transfusion QOL Assessment
- Boston, MassachusettsDana Farber Cancer Institute
2022-01-06
Jan 6, 2022A
Recruiting
- Myelodysplastic Syndrome
- Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
2021-07-21
Jul 21, 2021U
Active, not recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
- Rochester, New YorkUniversity of Rochester
2022-01-04
Jan 4, 2022S
Withdrawn
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia (CMML)
- (no location specified)
2021-08-09
Aug 9, 2021Y
Withdrawn
- MDS
- New Haven, ConnecticutYale University; Smilow Cancer Center
2022-01-06
Jan 6, 2022P
Recruiting
- Myelodysplastic Syndromes
- Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
2021-09-14
Sep 14, 2021N
Enrolling by invitation
- Acute Lymphoblastic Leukemia
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022S
Suspended
- Myelodysplastic Syndromes
- Allogeneic umbilical cord mesenchymal stem cells
- Decitabine
- Hohhot, Inner Mongolia, ChinaInner Mongolia International Mongolian Hospital
2022-02-14
Feb 14, 2022U
Recruiting
- Myelodysplasia
- Grenoble, FranceCHU de GRENOBLE ALPES
2021-10-01
Oct 1, 2021A
Not yet recruiting
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- AMG 176
- Azacitidine
- (no location specified)
2022-01-13
Jan 13, 2022